Those with a finger on the pulse of the US Drug Supply Chain Security Act (DSCSA) will have heard from all rooftops by now that FDA has granted all pharmaceutical Trading Partners a 12-month Stabilization Period. If […]
Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials
Despite potential short-cuts, drug development is a lengthy and risky process that culminates in marketing approval. However, just because a drug achieves regulatory approval, does not mean that it will be instantly available to those in need. […]
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, I had no idea how complex it was.
In 2019, I graduated with Distinction from the roller-coaster that was my one-year full-time MSc in Finance and Investment Management at the University of Aberdeen, Scotland.
Considering the importance of antibiotics for our healthcare, the issue of a dwindling development pipeline must be addressed. This article outlines various economic suggestions.
Planning and financing healthcare is a challenging task for individuals, private insurance providers and governments. Public and private insurances must cater for a vast number of people ideally equally across all income classes. Indeed, increased healthcare spending […]